Image: Barry Shimmon[CC BY-SA 2.0], via Geograph
Industry partners get access to £400 million of research to “accelerate pace” medicines reach patients
Cancer Research UK has launched an innovation unit for drug discovery and commercialisation that aims to “combine the power of academia and industry.”
Cancer Research Horizons will give industry partners access to the charity’s network of 4,000 cancer researchers and to over £400 million of research annually in order to “accelerate the pace” at which new discoveries reach patients, CRUK said.
This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com
Pivot-RP users can log in and view the article via this link.